Product DescriptionNelfinavir Mesylate (NFV), Purified Small Molecule, suitable to Neutralize.
Application(s)Neutralize
Application DetailsHuman immunodeficiency virus protease inhibitor. Potently inhibits HIV-1 protease (Ki = 2 nM) in vitro (5).
TargetNelfinavir Mesylate (NFV)
Target Host SpeciesSpecies Independent
Purity Description>98% (HPLC); NMR (Conforms)
Purity %> 98%
FormatDry, white powder.
Reconstitution InstructionsSoluble in DMSO. May be dissolved in DMSO up to 70 mg/mL.
Storage InstructionsStore desiccated as supplied at -20°C for up to 2 years. Store solutions at -20°C for up to 1 month. Prevent multiple freeze-thaw cycles.
Batch NumberPlease see item label.
Expiration DateStore desiccated as supplied at -20°C for up to 2 years. Store solutions at -20°C for up to 1 month. Prevent multiple freeze-thaw cycles.
Alternative NamesMethanesulfonate; AG-1343; Nelfinavir; CAS 159989-65-8
Scientific BackgroundPharmacology: Nelfinavir is a clinically useful anti-HIV agent acting via inhibition of HIV-1 protease (Ki=2 nM) (1). It also displays efficacy in cancer, malaria, tuberculosis and SARS (2). Displays broad spectrum anticancer activity and induces endoplasmic reticulum stress, autophagy and apoptosis in vitro and in vivo (3). Inhibits the growth of HER2-positive breast cancer cells via inhibition of HSP90 through a novel mechanism (4). PubChem CID: 64142.
Product is sold for research use only, Not for human therapeutic use or for medicinal purposes.
General ReferencesM Olmo and D Podzamczer Expert Opin. Drug Metab. Toxicol. 2006 2:285. A Bruening et al. Curr. Mol. Pharmacol. 2010 3:91. JJ Gills et al. Clin. Cancer Res. 2007 13:5183. JS Shim et al. J. Natl. Cancer Inst. 2012 104:1576. Kaldor SW, et al.J Med Chem, 1997,40(24):3979-85.